|
|
Other links at Articles > Rheumatology |
| 2. |
Pegloticase Improves Clinical Outcomes of Severe, Refractory Gout
|
|
|
Pegloticase quickly lowers serum urate levels and relieves pain in a substantial proportion of patients with severe, treatment-refractory gout, according to phase III clinical trial results presented Sunday at the American College of Rheumatology Annual Scientific Meeting in San Francisco. Reuters Health Information
|
|
|